You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NKTR Sale Disclosure
Robin Howard W · SEC Form 4 · Filed Jun 18, 2026
Sale
Calculated transaction value
$318.02K
Robin Howard W President & CEO
NKTR
Nektar Therapeutics
NKTR
Transaction date
Jun 16, 2026
Public filing date
Jun 18, 2026
Filing lag
Filed 2 days later
NKTR daily price context
Close on/before transaction
$60.27
Jun 16, 2026
First close after public filing
$65.7
Jun 22, 2026
30-day return after filing
-1.31%
Through Jul 20, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,303 shares @ $59.97
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-276236
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.22M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nektar Therapeutics NKTR | Sale | Jun 17, 2026 | $334.45K |
| Nektar Therapeutics NKTR | Sale | Jun 17, 2026 | $277.43K |
| Nektar Therapeutics NKTR Current | Sale | Jun 16, 2026 | $318.02K |
| Nektar Therapeutics NKTR | Sale | Jun 16, 2026 | $285.15K |